Degenerative Neurological and Neuromuscular Disease

期刊简介：Degenerative Neurological and Neuromuscular Disease is an international, peer-reviewed, open access journal focusing on research into all aspects of degenerative neurological and neuromuscular disease, identification of therapeutic targets and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival and quality of life for the patient. Degenerative Neurological and Neuromuscular Disease will no longer consider meta-analyses for publication. Specific topics covered in the journal include: Biological and clinical basis of degenerative neurological diseases including Multiple Sclerosis, Huntington’s disease, Alzheimer’s Disease, Parkinson’s Disease and Friedreich’s ataxia Biological and clinical basis of degenerative neuromuscular diseases including Amyotrophic Lateral Sclerosis, Muscular Dystrophy, Myasthenia Gravis and Spinal Muscular Atrophy. Natural history, epidemiology, detection and screening of these conditions Pathophysiology, causative agents and vectors, cellular research and biomarkers Identification of biotargets and agents with novel mechanisms of action Optimal clinical use of existing agents, including combination therapies Complementary and alternative medicine Palliative care Patient adherence, quality of life, satisfaction Health economic evaluations This journal is a member of and subscribes to the principles of the Committee on Publication Ethics(COPE). It welcomes submitted papers covering original research, reviews and evaluations, guidelines, expert opinion and commentary, and extended reports. The journal will consider negative or null results that do not support a previously stated hypothesis and still meet publication requirements.

【译文】《退行性神经和神经肌肉疾病》是一本经过同行评审的国际开放获取期刊，专注于对退行性神经和神经肌肉疾病各个方面的研究、治疗靶点的确定以及预防性和综合治疗干预措施的最佳使用，以实现改善结果、提高患者的生存率和生活质量。退行性神经和神经肌肉疾病将不再考虑发表荟萃分析。该杂志涵盖的具体主题包括： 退行性神经系统疾病的生物学和临床基础，包括多发性硬化症、亨廷顿病、阿尔茨海默病、帕金森病和弗里德赖希共济失调。 退行性神经肌肉疾病的生物学和临床基础，包括肌萎缩侧索硬化症、肌营养不良症、重症肌无力和脊髓性肌萎缩症。自然史、流行病学、这些病症的检测和筛查 病理生理学、致病因子和载体、细胞研究和生物标志物 识别生物靶点和具有新作用机制的药物 现有药物的最佳临床使用，包括联合疗法 补充和替代医学 姑息治疗 患者依从性、生活质量、满意度 健康经济评估 本期刊是出版道德委员会 (COPE) 的成员并遵守其原则。它欢迎提交涵盖原创研究、评论和评估、指南、专家意见和评论以及扩展报告的论文。该期刊将考虑不支持先前陈述的假设但仍满足发表要求的阴性或无效结果。